Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
110479804 | 11047980 | 4 | F | 2005 | 20160804 | 20150420 | 20160815 | EXP | US-009507513-1504USA017804 | MERCK | 0.00 | M | Y | 93.42000 | KG | 20160815 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
110479804 | 11047980 | 1 | PS | PROPECIA | FINASTERIDE | 1 | Oral | 1 MG, UNK | U | 20788 | 1 | MG | FILM-COATED TABLET | ||||||
110479804 | 11047980 | 2 | SS | FINASTERIDE. | FINASTERIDE | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | FILM-COATED TABLET | QD | |||||
110479804 | 11047980 | 3 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Oral | UNK | 0 | ||||||||||
110479804 | 11047980 | 4 | C | ZESTRIL | LISINOPRIL | 1 | Unknown | UNK | 0 | ||||||||||
110479804 | 11047980 | 5 | SS | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Oral | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
110479804 | 11047980 | 1 | Alopecia |
110479804 | 11047980 | 2 | Prostatomegaly |
110479804 | 11047980 | 3 | Depression |
110479804 | 11047980 | 4 | Hypertension |
110479804 | 11047980 | 5 | Depression |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
110479804 | 11047980 | DS |
110479804 | 11047980 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
110479804 | 11047980 | Anxiety | |
110479804 | 11047980 | Asthenia | |
110479804 | 11047980 | Decreased appetite | |
110479804 | 11047980 | Depression | |
110479804 | 11047980 | Disturbance in attention | |
110479804 | 11047980 | Dyspepsia | |
110479804 | 11047980 | Dyspnoea | |
110479804 | 11047980 | Ejaculation disorder | |
110479804 | 11047980 | Erectile dysfunction | |
110479804 | 11047980 | Essential hypertension | |
110479804 | 11047980 | Fatigue | |
110479804 | 11047980 | Fibromyalgia | |
110479804 | 11047980 | Gynaecomastia | |
110479804 | 11047980 | Hypothyroidism | |
110479804 | 11047980 | Nocturia | |
110479804 | 11047980 | Overdose | |
110479804 | 11047980 | Polyarthritis | |
110479804 | 11047980 | Renal failure | |
110479804 | 11047980 | Restlessness | |
110479804 | 11047980 | Semen volume decreased | |
110479804 | 11047980 | Sexual dysfunction | |
110479804 | 11047980 | Sleep disorder | |
110479804 | 11047980 | Urinary hesitation | |
110479804 | 11047980 | Urine flow decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
110479804 | 11047980 | 1 | 1997 | 0 | ||
110479804 | 11047980 | 3 | 1990 | 0 | ||
110479804 | 11047980 | 4 | 1995 | 0 |